EFFECTIVENESS OF A PSEUDOMONAS AERUGINOSA ERADICATION PROTOCOL IN CHILDREN WITH CYSTIC FIBROSIS

被引:0
|
作者
Blanchard, A. C. [1 ]
Horton, E. [2 ]
Stanojevic, S. [2 ]
Taylor, L. [2 ]
Waters, V. J. [1 ]
Ratjen, F. [2 ]
机构
[1] Univ Toronto, Dept Pediat, Hosp Sick Children, Div Infect Dis, 555 Univ Ave, Toronto, ON, Canada
[2] Univ Toronto, Dept Pediat, Hosp Sick Children, Div Resp Med, Toronto, ON, Canada
关键词
D O I
暂无
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
335
引用
收藏
页码:319 / 319
页数:1
相关论文
共 50 条
  • [41] Pseudomonas aeruginosa aggregation and Psl expression in sputum is associated with antibiotic eradication failure in children with cystic fibrosis
    Morris, Amanda J.
    Yau, Yvonne C. W.
    Park, Subin
    Eisha, Shafinaz
    McDonald, Nancy
    Parsek, Matthew R.
    Howell, P. Lynne
    Hoffman, Lucas R.
    Dao Nguyen
    DiGiandomenico, Antonio
    Rooney, Ashley M.
    Coburn, Bryan
    Grana-Miraglia, Lucia
    Wang, Pauline
    Guttman, David S.
    Wozniak, Daniel J.
    Waters, Valerie J.
    SCIENTIFIC REPORTS, 2022, 12 (01):
  • [42] IMPACT OF SUCCESSFUL ERADICATION OF PSEUDOMONAS AERUGINOSA ON LONG TERM OUTCOMES IN CYSTIC FIBROSIS
    Hamblett, N. M.
    Rosenfeld, M.
    Kloster, M.
    Gibson, R.
    Retsch-Bogart, G. Z.
    Thompson, V.
    Ramsey, B.
    PEDIATRIC PULMONOLOGY, 2014, 49 : 317 - 317
  • [43] EVALUATION OF INHALED TOBRAMYCIN IN EARLY ERADICATION OF PSEUDOMONAS AERUGINOSA IN INFANTS WITH CYSTIC FIBROSIS
    Choi, J.
    Novak, K. J.
    Thompson, R.
    PEDIATRIC PULMONOLOGY, 2018, 53 : 275 - 275
  • [44] Factors influencing the acquisition and eradication of early Pseudomonas aeruginosa infection in cystic fibrosis
    Jackson, Lindsay
    Waters, Valerie
    JOURNAL OF CYSTIC FIBROSIS, 2021, 20 (01) : 8 - 16
  • [45] No benefit of longer eradication therapy of Pseudomonas aeruginosa primoinfections in pediatric cystic fibrosis
    F. Claude
    I. Rochat
    G. M. Hafen
    BMC Research Notes, 12
  • [46] No benefit of longer eradication therapy of Pseudomonas aeruginosa primoinfections in pediatric cystic fibrosis
    Claude, F.
    Rochat, I.
    Hafen, G. M.
    BMC RESEARCH NOTES, 2019, 12 (1)
  • [47] Eradication of Pseudomonas aeruginosa in cystic fibrosis patients with inhalation of dry powder tobramycin
    Akkerman-Nijland, Anne M.
    Yousofi, Mina
    Rottier, Bart L.
    Van der Vaart, Hester
    Burgerhof, Johannes G. M.
    Frijlink, Henderik W.
    Touw, Daan J.
    Koppelman, Gerard H.
    Akkerman, Onno W.
    THERAPEUTIC ADVANCES IN RESPIRATORY DISEASE, 2020, 14
  • [48] Pseudomonas aeruginosa eradication therapy on Cystic Fibrosis-Guideline and clinical routine
    Einhorn, Klaus
    Ballmann, Manfred
    EUROPEAN RESPIRATORY JOURNAL, 2018, 52
  • [49] Eradication Therapy against Pseudomonas aeruginosa in Non-Cystic Fibrosis Bronchiectasis
    Orriols, Ramon
    Hernando, Rosana
    Ferrer, Adelaida
    Terradas, Sonia
    Montoro, Bruno
    RESPIRATION, 2015, 90 (04) : 299 - 305
  • [50] Economic effects of an eradication protocol for first appearance of Pseudomonas aeruginosa in cystic fibrosis patients: 1995 vs. 2009
    Lillquist, Yolanda P.
    Cho, Eva
    Davidson, A. George F.
    JOURNAL OF CYSTIC FIBROSIS, 2011, 10 (03) : 175 - 180